CLINICAL_TRIALS
trial_result
· 2021-04-20
Clinical Trial Update: A Study of LY3375880 in Adults With Moderate-to-Severe Atopic Dermatitis [Phase 2]
Summary
Phase 2 study of LY3375880 in adults with moderate-to-severe atopic dermatitis was terminated; results posted in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Atopic Dermatitis | Phase 2 | Status: TERMINATED | Results posted: 2021-04-20